Unknown

Dataset Information

0

Current Evidence and Recommendations for Rate Control in Atrial Fibrillation.


ABSTRACT: Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice, which is associated with substantial risk of stroke and thromboembolism. As an arrhythmia that is particularly common in the elderly, it is an important contributor towards morbidity and mortality. Ventricular rate control has been a preferred and therapeutically convenient treatment strategy for the management of AF. Recent research in the field of rhythm control has led to the advent of newer antiarrhythmic drugs and catheter ablation techniques as newer therapeutic options. Currently available antiarrhythmic drugs still remain limited by their suboptimal efficacy and significant adverse effects. Catheter ablation as a newer modality to achieve sinus rhythm (SR) continues to evolve, but data on long-term outcomes on its efficacy and mortality outcomes are not yet available. Despite these current developments, rate control continues to be the front-line treatment strategy, especially in older and minimally symptomatic patients who might not tolerate the antiarrhythmic drug treatment. This review article discusses the current evidence and recommendations for ventricular rate control in the management of AF. We also highlight the considerations for rhythm control strategy in the management of patients of AF.

SUBMITTER: Maan A 

PROVIDER: S-EPMC4711525 | BioStudies | 2013-01-01T00:00:00Z

SECONDARY ACCESSION(S): NCT00911508

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7118295 | BioStudies
2020-01-01 | S-EPMC7046539 | BioStudies
2020-01-01 | S-EPMC7199124 | BioStudies
2013-01-01 | S-EPMC3651784 | BioStudies
2017-01-01 | S-EPMC5403606 | BioStudies
2021-01-01 | S-EPMC7910819 | BioStudies
1000-01-01 | S-EPMC2950644 | BioStudies
2018-01-01 | S-EPMC6285381 | BioStudies
1000-01-01 | S-EPMC4180605 | BioStudies
2016-01-01 | S-EPMC4639470 | BioStudies